Functional and Structural Abnormalities in Deferoxamine Retinopathy: A Review of the Literature

Deferoxamine mesylate (DFO) is the most commonly used iron-chelating agent to treat transfusion-related hemosiderosis. Despite the clear advantages for the use of DFO, numerous DFO-related systemic toxicities have been reported in the literature, as well as sight-threatening ocular toxicity involvin...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Nicola, Maura, Barteselli, Giulio, Dell'Arti, Laura, Ratiglia, Roberto, Viola, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475708/
https://www.ncbi.nlm.nih.gov/pubmed/26167477
http://dx.doi.org/10.1155/2015/249617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475708/
https://www.ncbi.nlm.nih.gov/pubmed/26167477
http://dx.doi.org/10.1155/2015/249617

Ejemplares similares